The Tandem Fab format is engineered as a non-Fc containing bispecific antibody fragment where two distinct Antigen-Binding Fragments (Fabs) are connected in tandem, typically utilizing a flexible peptide linker. This modular architecture allows the Fabs to bind their respective targets simultaneously without steric hindrance, a crucial feature for engaging targets like T-cell receptors and tumor antigens. Crucially, this structure offers the robust thermal stability inherent to the disulfide-linked light and heavy chains within a Fab, effectively overcoming the inherent instability and aggregation issues often associated with monovalent single-chain variable fragments (scFvs) during manufacturing and storage. Consequently, the Tandem Fab is predominantly used in tumor immunology to create bispecific T-cell engagers (TCEs). Its smaller size enables favorable tissue penetration, and its lack of an Fc domain results in rapid systemic clearance, supporting localized therapeutic effects and reducing the risk of systemic toxicity. Ultimately, the modularity of this design greatly simplifies the engineering process for multi-specific engagement, accelerating the path to lead candidate identification.
Fig.1 The structure of conventional and camelidae monoclonal antibodies and of different antibody fragments.1
Are you currently facing challenges in achieving targeted delivery and maintaining therapeutic stability with complex antibody formats? Creative Biolabs Tandem Fab Generation Service helps you develop highly specific, stable bispecific antibody fragments through advanced recombinant DNA technology and high-throughput expression platforms. This modular design addresses the complexities of multi-target engagement, particularly for T-cell redirection and highly localized cancer therapies.
Contact our team for more Tandem Fab and get a Quote now!
Creative Biolabs leverages deep expertise in recombinant protein engineering to deliver bispecific fragments with superior development characteristics. Unlike conventional approaches that struggle with chain mispairing—a common bottleneck in multi-chain antibody production—our Tandem Fab strategy actively minimizes these complexities, ensuring high-fidelity assembly and maximum yield. We achieve this superior outcome through several key technical advantages:
Experience the Creative Biolabs Advantage - Get a Quote Today
A: The primary advantage is size and clearance. Tandem Fab is much smaller, allowing for enhanced tissue penetration, which is critical for targeting solid tumors. Furthermore, as it lacks an Fc region, it clears faster, potentially reducing systemic toxicity. If your goal is primarily to engage targets in functional in vitro assays or requires short half-life in vivo, Tandem Fab is an excellent choice.
A: Yes, the Tandem Fab format provides sufficient flexibility through the inter-Fab linker to accommodate simultaneous binding to closely spaced targets. However, binding fidelity can be sequence-dependent. We recommend providing detailed epitope mapping data or utilizing our upfront structural modeling service to ensure the best possible design and functional compatibility.
A: While yields are sequence-dependent, our high-yield expression systems generally produce sufficient material for extensive preclinical in vitro and early in vivo testing. Our purification process focuses on maximizing quality and homogeneity, often achieving purities above 95%, which is more critical for functional assays than sheer quantity.
A: Tandem Fab, being a fragment without the Fc domain, inherently has a shorter half-life than full IgG molecules. If a prolonged half-life is mandatory, we recommend exploring our Fc-fusion Tandem Fab variations or our full IgG bispecific platforms. Please reach out to discuss your specific PK/PD requirements.
A: We perform rigorous quality control, including biophysical characterization to ensure structural integrity and functional assays (e.g., SPR/BLI) to confirm high-affinity binding to both targets simultaneously. For T-cell engagers, we also offer T-cell activation and tumor cell cytotoxicity assays to ensure biological function is maintained.
Creative Biolabs' Tandem Fab Generation Service represents a cutting-edge solution for creating stable, modular, and functional bispecific antibody fragments. By simplifying complex engineering challenges, we accelerate lead candidate identification, enabling superior efficacy in addressing drug resistance and achieving precise therapeutic delivery. Our proven workflow, high-purity standards, and commitment to maintaining drug-like properties ensure your project moves forward with confidence and speed.
Reference
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY
SERVICES
PRODUCTS
PLATFORMS
